It is often described as a triple hormone receptor agonist because it targets three important receptor systems: GLP-1 receptor GIP receptor Glucagon receptor In simple terms, Retatrutide is designed to interact with biological pathways that may affect hunger, fullness, energy use, and metabolic response
Kind Patches GLP-1 (now renamed to Berberine Patches) contains berberine extract (8.75mg), pomegranate extract (1.75mg), cinnamon extract (2.75mg), B-vitamins, L-glutamine (3.5mg), and chromium (35mcg)
Prescription GLP-1 medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) mimic the rise in this hormone to slow down digestion and prompt you to stop eating
3 Cardiac arrhythmias affected 2-11% of participants on retatrutide versus 2% on placebo, but none were serious
Sources:
A growing number of evidence indicates that GLP-1-based therapies have anti-inflammatory effects in various cells, tissues, and organs by reducing the synthesis of pro-inflammatory cytokines and limiting immune cell infiltration